Friday July 24, 04:59 PM
BRIEF-Cyberonics provides update on depression post-approval study
July 24 (Reuters) - Cyberonics Inc (CYBX - news) :
* Provides update on depression post-approval study
* Says has
FDA approved co's proposal to amend protocol of its d-21
post-approval dosing study
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters (TRI.TO - news) .
NNNN
|
Send Article by Email
Send Article by IM
Blog This with Y! 360
Printable View
